Worakan Promphan

Dr. Worakan Promphan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2021 in Hearts
Verified
Journal Article
Open access
PDF file
WPWorakan Promphan
Worakan Promphan
Shakeel QureshiShakeel Qureshi
Shakeel Qureshi
The ductal stenting (DS) is currently an acceptable palliative treatment in newborns suffering with duct-dependent pulmonary circulation. However, this procedure remains technically a challenge in complex ductal morphology, which may eventually lead to detrimental outcomes. This review is mainly focused on pre-procedural planning, essential instruments and practical approaches for DS, and post-procedural care.

19 May 2023 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
SSShyam Sathanandam
Shyam Sathanandam
PMPatrick McNamara
Patrick McNamara
CPCarlos Pedra
Carlos Pedra
KTKatsuaki Toyoshima
Katsuaki Toyoshima
MSMalekzadeh-Milani Sophie
Malekzadeh-Milani Sophie
FIFrank Ing
Frank Ing
Patent ductus arteriosus (PDA) is a frequently encountered defect in infants born extremely premature (≤26 weeks’ gestation). Historically, closure of the PDA was performed using cyclooxygenase inhibitor medications or by surgical ligations. However, the benefits of PDA closure using these therapies have never been demonstrated, albeit studies have previously not focused on the extremely premature infants. Therefore, there was a worldwide trend toward conservative management of the PDA. With improved survival of extremely premature infants, comorbidities associated with the PDA has increased, resulting in finding alternate treatments such as transcatheter patent ductus arteriosus closure (TCPC) for this population. Currently, there is a renewed interest toward selective treatment of the PDA in this high-risk cohort of small infants. This Comprehensive Review article inspects the globally changing trends in the management of the PDA in premature infants, with a special focus on the rising adoption of TCPC. Moreover, this article compiles data from several neonatal networks worldwide to help understand the problem at hand. Understanding the current management of premature infants and their outcomes is fundamentally essential if pediatric cardiologists are to offer TCPC as a viable therapeutic option for this population. This article aims to serve as a guide for pediatric cardiologists on this topic by compiling the results on landmark clinical trials on PDA management and the controversies that arise from these trials. Comparative outcomes from several countries are presented, including interpretations and opinions of the data from experts globally. This is a step toward coming to a global consensus in PDA management in premature infants.

28 June 2021 in Japanese Journal of Radiology
Verified
Journal Article
Closed access
PDF file
SSSuvipaporn Siripornpitak
Suvipaporn Siripornpitak
ASApichaya Sriprachyakul
Apichaya Sriprachyakul
WPWorakan Promphan
Worakan Promphan
PMPirapat Mokarapong
Pirapat Mokarapong
SWSuthep Wanitkun
Suthep Wanitkun

1 January 2023 in Congenital Heart Disease
Verified
Journal Article
Open access
PDF file
SRSupaporn Roymanee
Supaporn Roymanee
NSNantawan Su-Angka
Nantawan Su-Angka
WPWorakan Promphan
Worakan Promphan
KWKanjarut Wongwaitaweewong
Kanjarut Wongwaitaweewong
JJJirayut Jarutach
Jirayut Jarutach
PPPimpak Prachasilchai
Pimpak Prachasilchai
Background: Ventricular septal defect (VSD) is the most common congenital heart disease. Transcatheter VSD closure is an effective treatment for patients with muscular and perimembranous VSD. However, there is a limit data for outlet VSD, especially impact to the aortic valve leaflet after transcatheter closure. This study aims to assess the outcomes of transcatheter closure of the outlet-type ventricular septal defect (OVSD) after 1 postoperative year. Methods: A retrospective study was performed including 50 patients who underwent transcatheter (n = 25) and surgical (n = 25) OVSD closure during the exact time frame at two medical centres. Results: The median age and body weight of patients in the transcatheter group were significantly higher than those of patients in the surgical group (7.0 vs. 2.8 years; 27.0 vs. 11.4 kg; p < 0.01). The defect size in the surgical group was significantly larger than that in the transcatheter group (5.0 vs. 3.0 mm; p < 0.01). All OVSD patients have successful transcatheter closure (100%) as effective as surgical closure. Less than small residual shunt was present 20% and 8% immediately after the procedure in the transcatheter and surgical groups (p = 0.50), which decreased to 12% and 4% at the 1-year follow-up (p = 0.61), respectively. No incidence of complete atrioventricular block and other complications was observed in both groups, and no significant differences were noted in the new onset or worsening of the aortic regurgitation in both groups (p = 1.0). Conclusions: Transcatheter treatment could be effectively and safely achieved for OVSD closure at 1-year follow-up.

1 January 2021 in European Journal of Radiology Open
Verified
Journal Article
Open access
SSSuvipaporn Siripornpitak
Suvipaporn Siripornpitak
UKUracha Kunjaru
Uracha Kunjaru
ASApichaya Sriprachyakul
Apichaya Sriprachyakul
WPWorakan Promphan
Worakan Promphan
PKPoomiporn Katanyuwong
Poomiporn Katanyuwong
To determine the type of pulmonary circulation (PC) in patients with tetralogy of Fallot (TOF) and pulmonary atresia (TOF-PA) with the use of computed tomographic angiography (CTA), and describe their clinical courses, corrective surgery and disease burden. 145 patients (median age 4 years, interquartile range: IQR2-8 years) were analyzed for PC which divided into 5 CTA-types and 11 subtypes based on presence of main pulmonary trunk (MPA) and confluent pulmonary arteries (confluence-PAs), presence of ductus arteriosus or major aortopulmonary collateral arteries (MAPCAs), respectively. Pulmonary arteries (PAs) were assessed by McGoon ratio and arborization. Corrective surgery or palliative management was recorded by type of PC. Disease burden was calculated as the sum of CTA, diagnostic angiography, and palliative management. The most common (N = 77, 53 %) PC was the presence of MPA with confluent-PAs (type-1) which was encountered mostly in TOF patients, followed by the presence of confluent-PAs with atretic MPA (type-2) (N = 47, 32 %) which found mainly in TOF-PA. McGoon ratio in type-1 (2.44 ± 0.84) was significantly larger than type-2 (1.61 ± 0.61) (median difference 0.84, 95 %CI 0.56–1.11, p < 0.001). Almost 2/3 of patients in type-1 (71 %) and 1/3 of patients in type-2 (34 %) achieved corrective surgery. There was no significant difference in amount of disease burden among the different PC, with the median value of 3 (IQR1-4). Types of PC allow suggestions for size and arborization of PAs and successful surgical correction with an inverse relationship with the numbers of MAPCAs. There is no significant difference in amount of disease burden among the types of PC.

1 October 2021 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
WPWorakan Promphan
Worakan Promphan
PMPirapat Mokarapong
Pirapat Mokarapong
KSKweekrong Sukhakul
Kweekrong Sukhakul
SQShakeel A. Qureshi
Shakeel A. Qureshi